| Drug Name: | Neostigmine (59-99-4) |
|---|---|
| PubChem ID: | 4456 |
| SMILES: | CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C |
| InchiKey: | ALWKGYPQUAPLQC-UHFFFAOYSA-N |
| Therapeutic Category: | Autonomic Agents, Cholinergic Agents, Cholinesterase Inhibitors, Enzyme Inhibitors, Neurotransmitter Agents, Parasympathomimetics, Peripheral Nervous System Agents |
| Molecular Weight (dalton) | : | 223.296 |
| LogP | : | 1.9437 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 29.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category